Lilly, Disney launch type 1 diabetes education effort

Share this article:

Lilly Diabetes is collaborating with Disney and the mother of the Jonas Brothers for a disease awareness campaign aimed at parents of children with type 1 diabetes. 

The effort includes a hub on Disney's, custom books by Disney Publishing Worldwide for kids with diabetes and the Once Upon a Time contest featuring Denise Jonas, whose son Nick was diagnosed at age 13.

For the contest, Lilly and Disney will invite parents and caregivers to submit a poem, story or essay about their child's experiences with type 1 diabetes. The winning entry, as determined by a panel of independent judges, will be featured on Disney and the winning family will be sent to the 2012 Friends for Life conference, for children with diabetes, in Orlando. The contest is open through November 30. 

Custom books aimed at children of various ages and life-stages with diabetes will launch over the next few years, said Disney Publishing Worldwide and Lilly, and will be distributed through doctors' offices. The books will look at challenges of childhood diabetes such as returning to school after diagnosis, going to birthday parties and playing sports. One book, part of the Mickey Mouse Clubhouse series, introduces Coco, a monkey with type 1 diabetes. 

A microsite at will offer advice on topics like planning vacations, sleepovers and extracurricular activities for kids with diabetes. Content will be refreshed monthly, with contributions from dieticians, psychologists, nurses and families. 

Each year, more than 13,000 young people are diagnosed with type 1 diabetes in the US, according to CDC data. 

Lilly diabetes products include Tradjenta, Humalog, Byetta and Glucagon.

Share this article:
You must be a registered member of MMM to post a comment.


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...